After J&J News, Pfizer CEO Says It Can Deliver 10% More Vaccine Doses To U.S.

Albert Bourla, Pfizer CEO looks on at the Pfizer Kalamazoo Manufacturing Site February 19, 2021, in Portage, Michigan. (Photo by Brendan Smialowski / AFP) (Photo by BRENDAN SMIALOWSKI/AFP via Getty Images)
April 13, 2021 5:39 p.m.
EDITORS' NOTE: TPM is making our COVID-19 coverage free to all readers during this national health crisis. If you’d like to support TPM's reporters, editors and staff, the best way to do so is to become a member.

Pfizer CEO Albert Bourla on Tuesday said that the pharmaceutical giant ramped up production of its two-dose COVID-19 vaccine and can deliver 10 percent more doses to the U.S. than it previously agreed to produce by the end of May.

Bourla said Pfizer is also on track to deliver a total of 300 million doses to the country two weeks earlier than expected.

The Pfizer CEO’s announcement was issued the same day that the Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC) released a joint recommendation advising health care providers to stop administering Johnson & Johnson’s COVID-19 vaccine “out of an abundance of caution,” following an FDA advisory reporting that six women in the U.S. developed a rare blood-clotting disorder that led to the death of one woman and put another in critical condition.

During the FDA and CDC’s press conference on their announcement, acting FDA Commissioner Janet Woodcock said the pause was expected to last for “a matter of days.”

Shortly after the FDA and CDC held a press conference on its recommended pause of J&J vaccine distribution, several states moved to cease its distribution.

Earlier Tuesday, White House COVID-19 Response Coordinator Jeff Zients said that federal health agencies’ recommendation to pause J&J’s COVID-19 vaccines wouldn’t impede the Biden administration’s vaccine rollout program.

“This announcement will not have a significant impact on our vaccination plan: Johnson & Johnson vaccine makes up less than 5 percent of the recorded shots in arms in the United States to date,” Zients said in a statement.

Zients said that the 300 million doses of Pfizer and Moderna’s vaccines secured by the Biden administration indicated that the country has “more than enough supply” to continue its current rate of 3 million vaccinations per day. Zients also assured that President Biden’s goal of 200 million shots by his 100th day in office is still in reach.

Key Coronavirus Crisis Links

TPM’s COVID-19 hub.
Josh Marshall’s Twitter List of Trusted Experts (Epidemiologists, Researchers, Clinicians, Journalists, Government Agencies) providing reliable real-time information on the COVID-19 Crisis.
COVID-19 Tracking Project (updated data on testing and infections in the U.S.).
Johns Hopkins Global COVID-19 Survey (most up to date numbers globally and for countries around the world). (extensive source of information and data visualizations on COVID-19 Crisis — discussion of data here).
Latest News
Comments are now Members-Only

Non-members are still able to read comments, but will no longer be able to participate. To join the conversation, sign up now and get:

30% Off Annual Prime Membership

TPM strives to build as inclusive a community as financially possible. We offer FREE memberships to those experiencing financial hardship and FREE memberships for students.

View all options
Masthead Masthead
Founder & Editor-in-Chief:
Executive Editor:
Managing Editor:
Associate Editor:
Editor at Large:
General Counsel:
Head of Product:
Director of Technology:
Associate Publisher:
Front End Developer:
Senior Designer: